Literature DB >> 16980917

Therapeutic time window of methylprednisolone in acoustic injury.

Keiji Tabuchi1, Hidekazu Murashita, Shuhei Sakai, Tomofumi Hoshino, Isao Uemaetomari, Akira Hara.   

Abstract

HYPOTHESIS: This study aims to investigate the therapeutic time window of methylprednisolone in acoustic injury.
BACKGROUND: Although glucocorticoids have been widely used in the treatment of acoustic injury, the therapeutic time window of glucocorticoids in acoustic injury has never been examined.
METHODS: Mice were exposed to 4-kHz pure tone of 128-dB sound pressure level for 4 hours. Auditory brainstem response was examined before, immediately after, and 2 weeks after acoustic overexposure.
RESULTS: Methylprednisolone significantly improved the auditory brainstem response threshold shifts 2 weeks after acoustic overexposure when it was administered before or immediately after acoustic overexposure, but not when administered 3 hours after acoustic overexposure.
CONCLUSION: The present findings suggest that methylprednisolone possesses protective effects against acoustic injury of the cochlea with a short therapeutic time window.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980917     DOI: 10.1097/01.mao.0000226313.82069.3f

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  10 in total

1.  IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Authors:  Shresh Pathak; Elliot Goldofsky; Esther X Vivas; Vincent R Bonagura; Andrea Vambutas
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

Review 2.  Pharmacological agents used for treatment and prevention in noise-induced hearing loss.

Authors:  Muhammed Sedat Sakat; Korhan Kilic; Sami Bercin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

3.  A corticosteroid-responsive transcription factor, promyelocytic leukemia zinc finger protein, mediates protection of the cochlea from acoustic trauma.

Authors:  Marcello Peppi; Sharon G Kujawa; William F Sewell
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

4.  Characterisation of cochlear inflammation in mice following acute and chronic noise exposure.

Authors:  Winston J T Tan; Peter R Thorne; Srdjan M Vlajkovic
Journal:  Histochem Cell Biol       Date:  2016-04-25       Impact factor: 4.304

5.  Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss.

Authors:  Jianxin Bao; Michelle Hungerford; Randi Luxmore; Dalian Ding; Ziyu Qiu; Debin Lei; Aizhen Yang; Ruqiang Liang; Kevin K Ohlemiller
Journal:  Hear Res       Date:  2013-06-18       Impact factor: 3.208

Review 6.  Emerging treatments for noise-induced hearing loss.

Authors:  Naoki Oishi; Jochen Schacht
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-20       Impact factor: 4.191

Review 7.  The role of glucocorticoids for spiral ganglion neuron survival.

Authors:  David Xu Jin; Zhaoyu Lin; Debin Lei; Jianxin Bao
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

8.  Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise.

Authors:  George Psillas; Pavlos Pavlidis; Ioannis Karvelis; George Kekes; Victor Vital; John Constantinidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-08       Impact factor: 2.503

9.  Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.

Authors:  Lukas D Landegger; Clemens Honeder; Chengjing Zhu; Hanna Schöpper; Elisabeth Engleder; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  J Negat Results Biomed       Date:  2016-05-11

10.  Glucocorticoids protect HEI-OC1 cells from tunicamycin-induced cell damage via inhibiting endoplasmic reticulum stress.

Authors:  Zhibiao Liu; Bing Fei; Lisheng Xie; Jin Liu; Xiaorui Chen; Wenyan Zhu; Lingyun Lv; Wei Ma; Ziwen Gao; Jie Hou; Wandong She
Journal:  Open Life Sci       Date:  2021-07-01       Impact factor: 0.938

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.